NAUT

Nautilus Biotechnolgy, Inc. (NAUT) PESTLE Analysis Analysis (2026)

Invetso Score: 4.4/10 — Balanced · Last Updated: 2026-09-01

Political

No major political or regulatory catalyst is evident from the current data.

The company’s small-cap profile means policy or government-contract exposure could matter, but no specific change is indicated this month.

Economic

Liquidity remains strong with a current ratio of 10.14 and cash ratio of 1.52, supporting near-term resilience.

However, profitability and cash generation remain deeply negative, with TTM operating cash flow and free cash flow both negative and margins still severely compressed.

Social

No new social or customer-demand developments are visible in the fresh data.

Investor sentiment is likely still driven more by financial performance than by brand or adoption trends.

Technological

R&D intensity remains high relative to revenue, suggesting continued investment in product development.

That said, the latest TTM results still show no evidence of operating leverage from those investments.

Legal

No new litigation, compliance, or legal-risk news was reported this month.

The balance sheet remains manageable, with debt-to-equity at 0.21 and no sign of immediate covenant stress in the data.

Environmental

No material environmental developments were reported in the latest news flow.

There is no fresh evidence of ESG-related cost pressure or regulatory impact this month.

Overall Score

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Nautilus Biotechnolgy, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →